{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:18:25Z","timestamp":1789492705912,"version":"build-2803163510"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate the prognostic significance of baseline subretinal fluid (SRF) optical density ratio (ODR) in first-onset central serous chorioretinopathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective study included patients with a new diagnosis of central serous chorioretinopathy, no prior retinal disease, and at least 3 months of follow-up. Eyes were categorized as resolved or nonresolved based on SRF resolution at 3 months. Optical density ratio was calculated as the ratio between SRF and vitreous optical densities on baseline optical coherence tomography scans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Thirty-nine patients (33 men, 6 women; mean age 41.4 \u00b1 9.1 years) met the inclusion criteria. At 3 months, SRF resolved in 19 eyes and persisted in 20 eyes. Baseline ODR was significantly higher in the nonresolved group compared with the resolved group (1.03 \u00b1 0.32 vs. 0.80 \u00b1 0.27;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.018). Visual acuity at follow-up was significantly better in the resolved group (20\/21.4 [logarithm of the minimum angle of resolution 0.03 \u00b1 0.05] vs. 20\/26.4 [logarithm of the minimum angle of resolution 0.12 \u00b1 0.16];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.035). No significant differences were found between groups in age, sex, or choroidal thickness. In multivariate logistic regression, ODR remained the only independent predictor of SRF persistence at 3 months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Baseline ODR is associated with both fluid persistence and visual outcomes. As the only independent predictor of persistent SRF in this cohort, ODR shows promise as a potential prognostic biomarker requiring no additional cost to identify patients at higher risk for chronic disease at initial presentation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004763","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T20:00:10Z","timestamp":1767643210000},"page":"881-887","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["OPTICAL DENSITY RATIO AS A PROGNOSTIC BIOMARKER FOR CHRONICITY IN CENTRAL SEROUS CHORIORETINOPATHY"],"prefix":"10.1097","volume":"46","author":[{"given":"Meira","family":"Neudorfer","sequence":"first","affiliation":[{"name":"Gray Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel;"},{"name":"Department of Ophthalmology, Sourasky Tel-Aviv Medical Center, Tel Aviv, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3797-1938","authenticated-orcid":false,"given":"Miri M.","family":"Fogel Levin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Leshno","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel;"},{"name":"Department of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Brakin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Sourasky Tel-Aviv Medical Center, Tel Aviv, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adiel","family":"Barak","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel;"},{"name":"Department of Ophthalmology, Sourasky Tel-Aviv Medical Center, Tel Aviv, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinah","family":"Zur","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel;"},{"name":"Department of Ophthalmology, Sourasky Tel-Aviv Medical Center, Tel Aviv, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Loewenstein","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel;"},{"name":"Department of Ophthalmology, Sourasky Tel-Aviv Medical Center, Tel Aviv, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Moroz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulamit","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel;"},{"name":"Department of Ophthalmology, Sourasky Tel-Aviv Medical Center, Tel Aviv, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: a review of epidemiology and pathophysiology","volume":"41","author":"Liew","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"R2-20260915","first-page":"27","article-title":"Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging","volume":"34","author":"Kaye","year":"2020","journal-title":"Eye"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: recent findings and new physiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"van Rijssen","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archopht.1994.01090200063023","article-title":"Digital indocyanine green videoangiography of central serous chorioretinopathy","volume":"112","author":"Guyer","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/bjo.68.11.815","article-title":"Long-term follow-up of central serous chorioretinopathy","volume":"68","author":"Gilbert","year":"1984","journal-title":"Br J Ophthalmol"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central serous chorioretinopathy: update on pathophysiology and treatment","volume":"58","author":"Nicholson","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial","volume":"125","author":"van Dijk","year":"2018","journal-title":"Ophthalmology"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/IAE.0b013e3182680a66","article-title":"Type 1 neovascularization in chronic central serous chorioretinopathy","volume":"32","author":"Fung","year":"2012","journal-title":"Retina"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/bjo.87.12.1453","article-title":"Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level","volume":"87","author":"Chan","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/02713683.2013.824986","article-title":"Obstructive sleep apnea in patients with central serous chorioretinopathy","volume":"39","author":"Yava\u015f","year":"2014","journal-title":"Curr Eye Res"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1097\/IAE.0000000000000929","article-title":"Baseline spectral-domain OCT hyperreflective foci as a predictor of visual outcome and recurrence for central serous chorioretinopathy","volume":"36","author":"Lee","year":"2016","journal-title":"Retina"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.2147\/OPTH.S233273","article-title":"Baseline predictive factors of visual outcome and persistence of subretinal fluid based on morphologic changes in spectral domain optical coherence tomography in patients with idiopathic central serous chorioretinopathy","volume":"13","author":"Suwal","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12886-024-03711-3","article-title":"Fluorescein angiography patterns and subretinal hyperreflective material predict subthreshold micropulse laser response in chronic central serous chorioretinopathy","volume":"24","author":"Iovino","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"23940","DOI":"10.1038\/s41598-024-75275-7","article-title":"Optical coherence tomography-derived biomarkers associated with recurrence in central serous chorioretinopathy: a real-world longitudinal analysis","volume":"14","author":"Seiler","year":"2024","journal-title":"Sci Rep"},{"key":"R16-20260915","first-page":"1623","article-title":"Optical density of subretinal fluid in retinal detachment","volume":"36","author":"Leshno","year":"2016","journal-title":"Retina"},{"key":"R17-20260915","first-page":"1477","article-title":"Optical density ratio of the subretinal fluid in choroidal melanoma and metastasis","volume":"40","author":"Leshno","year":"2020","journal-title":"Retina"},{"key":"R18-20260915","first-page":"1078","article-title":"Subretinal fluid optical density and spectral-domain optical coherence tomography characteristics for the diagnosis of circumscribed choroidal hemangioma","volume":"42","author":"Zur","year":"2022","journal-title":"Retina"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/tvst.9.11.16","article-title":"Protein composition of the subretinal fluid suggests selective diffusion of vitreous proteins in retinal detachment","volume":"9","author":"Poulsen","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/tvst.7.1.3","article-title":"Proteome and metabolome of subretinal fluid in central serous chorioretinopathy and rhegmatogenous retinal detachment: a pilot case study","volume":"7","author":"Kowalczuk","year":"2018","journal-title":"Transl Vis Sci Technol"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1167\/iovs.13-12382","article-title":"Correlation between reflectivity of subretinal fluid in OCT images and concentration of intravitreal VEGF in eyes with diabetic macular edema","volume":"54","author":"Sonoda","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3109\/02713683.2014.888454","article-title":"Blood components and OCT reflectivity evaluated in animal model","volume":"39","author":"Sonoda","year":"2014","journal-title":"Curr Eye Res"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","article-title":"Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy","volume":"126","author":"Mrejen","year":"2019","journal-title":"Ophthalmology"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ajo.2014.11.011","article-title":"Optical density ratio in the subretinal fluid: differentiating chronic central serous chorioretinopathy and polypodial choroidal vasculopathy","volume":"159","author":"Baek","year":"2015","journal-title":"Am J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:00:50Z","timestamp":1789491650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004763","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}